SCHEMBL8963668

SCHEMBL8963668

Cc1[nH]c(-c2ccccc2)nc1CN1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.64
DRD4 P21917 2/20 0.64
DRD3 P35462 2/20 0.64
LMNA P02545 4/20 0.51
NPSR1 Q6W5P4 2/20 0.51
HTT P42858 1/20 0.51
CYP3A4 P08684 3/20 0.49
CYP2C19 P33261 2/20 0.49
CYP2C9 P11712 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ADORA3 P0DMS8 2/20 0.46
CNR1 P21554 2/20 0.46
HRH1 P35367 2/20 0.46
OPRK1 P41145 2/20 0.46
KCNH2 Q12809 2/20 0.46
GHSR Q92847 2/20 0.46
USP2 O75604 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lifarizine SCHEMBL676318 0.94 DRD2 (0.57) DRD2DRD4DRD3LMNANPSR1
Lifarizine SCHEMBL8963776 0.93 DRD2 (0.56) DRD2DRD4DRD3LMNANPSR1
SCHEMBL8963974 0.93 DRD3 (0.59) DRD2DRD4DRD3LMNANPSR1
SCHEMBL8963644 0.93 DRD3 (0.56) DRD2DRD4DRD3LMNANPSR1
SCHEMBL8963843 0.91 CYP3A4 (0.54) DRD2DRD4DRD3LMNANPSR1
SCHEMBL8963465 0.90 LMNA (0.57) DRD2DRD4DRD3LMNANPSR1
SCHEMBL8964060 0.90 DRD2 (0.53) DRD2DRD4DRD3LMNANPSR1
SCHEMBL8963779 0.89 CYP3A4 (0.53) DRD2DRD4DRD3LMNANPSR1
SCHEMBL9424741 0.89 DRD3 (0.55) DRD2DRD4DRD3LMNANPSR1
SCHEMBL8964084 0.88 DRD2 (0.52) DRD2DRD4DRD3LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0289227-B1 SUBSTITUTED IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES SYNTEX PHARMACEUTICALS LTD. (GB) 1992-04-08 EP claimed
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
EP-0289227-B1 SUBSTITUTED IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES SYNTEX PHARMACEUTICALS LTD. (GB) 1992-04-08 EP disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed
EP-0289227-A1 Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS LTD. (GB) 1988-11-02 EP disclosed